NCT02777567View on ClinicalTrials.gov

KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)

CompletedOBSERVATIONAL
Enrollment

315

Participants

Timeline

Start Date

September 29, 2016

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions
Non-Small Cell Lung Cancer
Trial Locations (1)

Unknown

Research Site, South Korea

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY